Oxidation contributes to low glutathione in the airways of children with cystic fibrosis

European Respiratory Journal

Volumn 44, Issue 1, 2014, Pages 122-129

  Kettle, Anthony J ^a   Turner, Rufus ^a   Gangell, Catherine L ^b   Harwood, D Timothy ^a   Khalilova, Irada S ^a   Chapman, Anna L ^a   Winterbourn, Christine C ^a   Sly, Peter D ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; GLUTATHIONE DERIVATIVE; GLUTATHIONE SULFONAMIDE; HYPOCHLOROUS ACID; MYELOPEROXIDASE; UNCLASSIFIED DRUG; ANTIOXIDANT; OXYGEN; PEROXIDASE; SULFONE;

AIRWAY; ARTICLE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; GLUTATHIONE METABOLISM; HUMAN; LUNG INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; RETROSPECTIVE STUDY; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; INFLAMMATION; LUNG; MASS SPECTROMETRY; METABOLISM; NEUTROPHIL; OXIDATIVE STRESS; PRESCHOOL CHILD; RESPIRATORY SYSTEM; THORAX RADIOGRAPHY;

ANTIOXIDANTS; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; GLUTATHIONE; HUMANS; HYPOCHLOROUS ACID; INFLAMMATION; LUNG; MASS SPECTROMETRY; NEUTROPHILS; OXIDATIVE STRESS; OXYGEN; PEROXIDASE; RADIOGRAPHY, THORACIC; RESPIRATORY SYSTEM; RETROSPECTIVE STUDIES; SULFONES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84903830061     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00170213     Document Type: Article

References (31)

1. Drumm ML, Ziady AG, Davis PB. Genetic variation and clinical heterogeneity in cystic fibrosis. Annu Rev Pathol 2012; 7: 267-282.
2. Grasemann H, Ratjen F. Early lung disease in cystic fibrosis. Lancet Resp Med 2013; 1: 148-157.
3. Pezzulo AA, Tang XX, Hoegger MJ, et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 2012; 487: 109-113.
4. Gustafsson JK, Ermund A, Ambort D, et al. Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J Exp Med 2012; 209: 1263-1272.
5. Downey DG, Bell SC, Elborn JS. Neutrophils in cystic fibrosis. Thorax 2009; 64: 81-88.
6. Sly PD, Gangell CL, Chen L, et al. Risk factors for bronchiectasis in children with cystic fibrosis. New Engl J Med 2013; 368: 1963-1970.
7. Kogan I, Ramjeesingh M, Li C, et al. CFTR directly mediates nucleotide-regulated glutathione flux. EMBO J 2003; 22: 1981-1989.
8. Linsdell P, Hanrahan JW. Glutathione permeability of CFTR. Am J Physiol 1998; 275: C323-C326.
9. Hudson VM. Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. Free Radic Biol Med 2001; 30: 1440-1461.
10. Cantin AM, North SL, Hubbard RC, et al. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987; 63: 152-157.
11. Roum JH, Buhl R, McElvaney NG, et al. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 1993; 75: 2419-2424.
12. Hull J, Vervaart P, Grimwood K, et al. Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 1997; 52: 557-560.
13. Galli F, Battistoni A, Gambari R, et al. Oxidative stress and antioxidant therapy in cystic fibrosis. Biochim Biophys Acta 2012; 1822: 690-713.
14. Kettle AJ, Chan T, Osberg I, et al. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am J Respir Crit Care Med 2004; 170: 1317-1323.
15. Winterbourn CC, Kettle AJ. Redox reactions and microbial killing in the neutrophil phagosome. Antioxid Redox Signal 2013; 18: 642-660.
16. Winterbourn CC. Radical scavenging by thiols and the fate of thiyl radicals. In: Jacob U, Reichman D, eds. Oxidative Stress and Redox Regulation. Springer, Dordrecht, 2013. pp. 43-58.
17. Thomson E, Brennan S, Senthilmohan R, et al. Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis. Free Radic Biol Med 2010; 49: 1354-1360.
18. Harwood DT, Kettle AJ, Winterbourn CC. Production of glutathione sulfonamide and dehydroglutathione from GSH by myeloperoxidase-derived oxidants and detection using a novel LC-MS/MS method. Biochem J 2006; 399: 161-168.
19. Xiong Y, Uys JD, Tew KD, et al. S-glutathionylation: from molecular mechanisms to health outcomes. Antioxid Redox Signal 2011; 15: 233-270.
20. Sly PD, Brennan S, Gangell C, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009; 180: 146-152.
21. Stick SM, Brennan S, Murray C, et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009; 155: 623-628.
22. Mott LS, Park J, Murray CP, et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012; 67: 509-516.
23. Chapman AL, Mocatta TJ, Shiva S, et al. Ceruloplasmin is an endogenous inhibitor of myeloperoxidase. J Biol Chem 2013; 288: 6465-6477.
24. Harwood DT, Kettle AJ, Brennan S, et al. Simultaneous determination of reduced glutathione, glutathione disulphide and glutathione sulphonamide in cells and physiological fluids by isotope dilution liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 3393-3399.
25. Hull J, Thomson AH. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 1998; 53: 1018-1021.
26. Day BJ. Glutathione: a radical treatment for cystic fibrosis lung disease. Chest 2005; 127: 12-14.
27. Dalle-Donne I, Milzani A, Gagliano N, et al. Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal 2008; 10: 445-473.
28. Pattison DI, Hawkins CL, Davies MJ. What are the plasma targets of the oxidant hypochlorous acid. A kinetic modeling approach. Chem Res Toxicol 2009; 22: 807-817.
29. Johnson D, Travis J. The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. J Biol Chem 1979; 254: 4022-4026.
30. Gould NS, Min E, Martin RJ, et al. CFTR is the primary known apical glutathione transporter involved in cigarette smoke-induced adaptive responses in the lung. Free Radic Biol Med 2012; 52: 1201-1206.
31. Griese M, Kappler M, Eismann C, et al. Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial. Am J Respir Crit Care Med 2013; 188: 83-89.